Travere Therapeutics Inc (TVTX) Q3 2024 Earnings Call Highlights ...

Nov 1, 2024 · Non-GAAP Adjusted R&D Expenses: $48.4 million for Q3 2024, compared to $53.8 million in Q3 2023. SG&A Expenses: $65.6 million for Q3 2024, down from $67.8 million in Q3 …

$48
OFF

Travere Therapeutics Inc (TVTX) Q3 2024 Earnings Call Highlights ...

2 weeks from now

Nov 1, 2024 · Non-GAAP Adjusted R&D Expenses: $48.4 million for Q3 2024, compared to $53.8 million in Q3 2023. SG&A Expenses: $65.6 million for Q3 2024, down from $67.8 million in Q3 …

yahoo.com

30%
OFF

Travere Therapeutics Inc (TVTX) Q3 2024 Earnings Call Highlights ...

2 weeks from now

Travere Therapeutics Inc (NASDAQ:TVTX) reported more than 30% growth in net sales over the last quarter, driven by the successful commercial launch of FILSPARI for IgA nephropathy. …

investing.com

$125
OFF

Travere Therapeutics, Inc. - MarketScreener.com

2 weeks from now

1 day ago · Travere Therapeutics Prices $125 Million Common Stock Offering Nov. 08: MT Travere Therapeutics, Inc., Q3 2024 Earnings Call, Oct 31, 2024 24-10-31: Earnings Flash …

marketscreener.com

$0.70
OFF

Travere Therapeutics (TVTX) Earnings Date And Reports 2025

2 weeks from now

Travere Therapeutics announced Q3 2024 earnings on October 31, 2024, reporting an EPS of -$0.70, which topped the consensus estimate of -$0.71 by $0.01. Quarterly revenue rose …

marketbeat.com

56%
OFF

Travere Therapeutics Revenue 2014-2024 - Stock Analysis

2 weeks from now

Dec 23, 2024 · Travere Therapeutics had revenue of $62.90M in the quarter ending September 30, 2024, with 69.56% growth. This brings the company's revenue in the last twelve months to …

stockanalysis.com

5%
OFF

Travere (TVTX) Q3 Earnings: How Key Metrics Compare To Wall

2 weeks from now

Oct 31, 2024 · Travere Therapeutics (TVTX) reported $62.9 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 69.5%. EPS of -$0.70 for …

nasdaq.com

0%
OFF

Travere Therapeutics (TVTX) Reports Q3 Loss, Tops Revenue …

2 weeks from now

Oct 31, 2024 · Travere (TVTX) delivered earnings and revenue surprises of 0% and 4.10%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies …

zacks.com

3%
OFF

New Jersey MarketBeats | US | Cushman & Wakefield

2 weeks from now

2 days ago · In New Jersey industrial market, the surge in unoccupied inventory, coupled with 5.6 msf of occupancy losses, drove the vacancy rate to 8.3% in Q4 2024, its highest level since …

cushmanwakefield.com